Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia · 2025
Innovations in randomized clinical trials in Nephrology: from study design to patient's activism.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pezzi Giuseppe, Arena Roberta, Papalia Giuliana, Sbano Raffaella, Iorio Fiorella, Summaria Chiara, Greco Angela, Greco Rosita, Malivindi Rocco, Veltri Pierangelo, La Manna Gaetano, Hu Lilio, Zaza Gianluigi, Provenzano Michele
Аннотация
Current clinical practice is guided by novel robust evidence from randomized clinical trials (RCT). These studies usually follow a rigorous prospective design with pre-defined visits and planned exams during follow-up. In the context of Nephrology, RCTs have been mainly designed to test the efficacy of new therapies in reducing the risk for kidney failure, estimated Glomerular Filtration Rate decline and mortality or cardiovascular events. However, the progress of informatics is reflected in an improvement and expansion of technologies and innovations in present and future RCTs. We here present some innovations and future directions of RCTs in Chronic Kidney Disease patients.